This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Neuropharma, S.a.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Maria Luisa Navarro Rico: Innovator in Pharmaceutical Research
Introduction
Maria Luisa Navarro Rico is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target critical health issues.
Latest Patents
Maria Luisa holds a patent for GSK-3 inhibitors. This invention relates to urea derivatives of formula (I) as inhibitors of glycogen synthase kinase 3β (GSK-3). The patent outlines processes for the preparation of these compounds, pharmaceutical compositions that include them, and their application in treating diseases where GSK-3 is involved, such as Alzheimer's disease and non-insulin dependent diabetes mellitus. She has 1 patent to her name.
Career Highlights
Maria Luisa is currently employed at Neuropharma, S.A., where she continues her research and development efforts. Her work focuses on innovative solutions to complex health challenges, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Maria Luisa has collaborated with notable colleagues, including Ana Martinez Gil and Miguel Medina Padilla. These partnerships have enhanced her research and contributed to the advancement of her projects.
Conclusion
Maria Luisa Navarro Rico is a trailblazer in the pharmaceutical industry, with her innovative work on GSK-3 inhibitors paving the way for potential treatments for serious diseases. Her contributions reflect her commitment to scientific advancement and improving healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile